Brokerage firm Deutsche Bank Maintains its rating on Allscripts Healthcare Solutions Inc(NASDAQ:MDRX). In a research note issued to the investors, the brokerage major Raises the price-target to $17.00 per share. The shares have been rated Buy. The rating by Deutsche Bank was issued on Aug 5, 2016.
In a different note, On May 13, 2016, Citigroup said it Maintains its rating on Allscripts Healthcare Solutions Inc. In the research note, the firm Raises the price-target to $13.00 per share. The shares have been rated ‘Neutral’ by the firm.
Allscripts Healthcare Solutions Inc (MDRX) shares turned negative on Wednesdays trading session with the shares closing down -0.27 points or -2.08% at a volume of 13,18,080. The pessimistic mood was evident in the company shares which never went considerably beyond the level of $13.14. The peak price level was also seen at $13.14 while the days lowest was $12.71. Finally the shares closed at $12.72. The 52-week high of the shares is $15.78 while the 52-week low is $11.47. According to the latest information available, the market cap of the company is $2,373 M.
Allscripts Healthcare Solutions Inc(MDRX) last announced its earnings results on Aug 4, 2016 for Fiscal Year 2016 and Q2.Company reported revenue of $396.60M. Analysts had an estimated revenue of $402.20M. Earnings per share were $0.14. Analysts had estimated an EPS of $0.14.
Several Insider Transactions has been reported to the SEC. On Jul 13, 2016, Dennis Olis (SVP of Operations) sold 7,000 shares at $14.00 per share price.Also, On Jul 6, 2016, James Hewitt (SVP Development) sold 17,500 shares at $13.00 per share price.On Jun 15, 2016, Richard J. Poulton (President) sold 10,000 shares at $13.03 per share price, according to the Form-4 filing with the securities and exchange commission.
Allscripts Healthcare Solutions Inc. is engaged in engaged in delivering Information Technology (IT) and services. The Company sells its solutions to physicians hospitals governments health systems health plans retail clinics retail pharmacies pharmacy benefit managers and post-acute organizations such as home health and hospice agencies. The Company operates through three segments: Clinical and Financial Solutions Population Health and Managed Services. The Companys solutions enable healthcare professionals with the data insights and connectivity. The Company offers Ambulatory Solutions Acute Care Solutions Population Health Management Solutions and services. Ambulatory solutions include Allscripts TouchWorks HER and Allscripts Professional HER among others. The Companys acute care offers clinical access financial and departmental solutions. The Company designs its population health management solutions for hospitals health systems among others.